BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11574017)

  • 1. Total synthesis of the microtubule-stabilizing agent (-)-laulimalide.
    Paterson I; De Savi C; Tudge M
    Org Lett; 2001 Oct; 3(20):3149-52. PubMed ID: 11574017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of the macrocyclic core of laulimalide.
    Paterson I; De Savi C; Tudge M
    Org Lett; 2001 Jan; 3(2):213-6. PubMed ID: 11430037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of microtubule-stabilizing agent (-)-laulimalide.
    Ghosh AK; Wang Y; Kim JT
    J Org Chem; 2001 Dec; 66(26):8973-82. PubMed ID: 11749630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of (-)-laulimalide.
    Wender PA; Hegde SG; Hubbard RD; Zhang L
    J Am Chem Soc; 2002 May; 124(18):4956-7. PubMed ID: 11982349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A de novo enantioselective total synthesis of (-)-laulimalide.
    Nelson SG; Cheung WS; Kassick AJ; Hilfiker MA
    J Am Chem Soc; 2002 Nov; 124(46):13654-5. PubMed ID: 12431077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubule-stabilizing marine metabolite laulimalide and its derivatives: synthetic approaches and antitumor activity.
    Mulzer J; Ohler E
    Chem Rev; 2003 Sep; 103(9):3753-86. PubMed ID: 12964883
    [No Abstract]   [Full Text] [Related]  

  • 7. Asymmetric total synthesis of (-)-laulimalide: exploiting the asymmetric glycolate alkylation reaction.
    Crimmins MT; Stanton MG; Allwein SP
    J Am Chem Soc; 2002 May; 124(21):5958-9. PubMed ID: 12022826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic approaches to the microtubule stabilizing agent (-)-laulimalide.
    Crimmins MT
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):944-59. PubMed ID: 12478725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.
    Pryor DE; O'Brate A; Bilcer G; Díaz JF; Wang Y; Wang Y; Kabaki M; Jung MK; Andreu JM; Ghosh AK; Giannakakou P; Hamel E
    Biochemistry; 2002 Jul; 41(29):9109-15. PubMed ID: 12119025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total synthesis of the microtubule stabilizing antitumor agent laulimalide and some nonnatural analogues: the power of Sharpless' asymmetric epoxidation.
    Ahmed A; Hoegenauer EK; Enev VS; Hanbauer M; Kaehlig H; Ohler E; Mulzer J
    J Org Chem; 2003 Apr; 68(8):3026-42. PubMed ID: 12688769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrocyclization via allyl transfer: total synthesis of laulimalide.
    Enev VS; Kaehlig H; Mulzer J
    J Am Chem Soc; 2001 Oct; 123(43):10764-5. PubMed ID: 11674020
    [No Abstract]   [Full Text] [Related]  

  • 12. Microtubule-stabilizing agents based on designed laulimalide analogues.
    Mooberry SL; Randall-Hlubek DA; Leal RM; Hegde SG; Hubbard RD; Zhang L; Wender PA
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8803-8. PubMed ID: 15161976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent.
    Liu J; Towle MJ; Cheng H; Saxton P; Reardon C; Wu J; Murphy EA; Kuznetsov G; Johannes CW; Tremblay MR; Zhao H; Pesant M; Fang FG; Vermeulen MW; Gallagher BM; Littlefield BA
    Anticancer Res; 2007; 27(3B):1509-18. PubMed ID: 17595769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.
    Hood KA; West LM; Rouwé B; Northcote PT; Berridge MV; Wakefield SJ; Miller JH
    Cancer Res; 2002 Jun; 62(12):3356-60. PubMed ID: 12067973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel 11-desmethyl analogues of laulimalide by Nozaki-Kishi coupling.
    Paterson I; Bergmann H; Menche D; Berkessel A
    Org Lett; 2004 Apr; 6(8):1293-5. PubMed ID: 15070320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of (-)-laulimalide analogues.
    Wender PA; Hegde SG; Hubbard RD; Zhang L; Mooberry SL
    Org Lett; 2003 Sep; 5(19):3507-9. PubMed ID: 12967311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total synthesis and biological evaluation of 11-desmethyllaulimalide, a highly potent simplified laulimalide analogue.
    Wender PA; Hilinski MK; Soldermann N; Mooberry SL
    Org Lett; 2006 Mar; 8(7):1507-10. PubMed ID: 16562928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
    Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
    Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.
    Gapud EJ; Bai R; Ghosh AK; Hamel E
    Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butitaxel analogues: synthesis and structure-activity relationships.
    Ali SM; Hoemann MZ; Aubé J; Georg GI; Mitscher LA; Jayasinghe LR
    J Med Chem; 1997 Jan; 40(2):236-41. PubMed ID: 9003522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.